Clinical trial Recruiting at 18 sites Observational Ages 18 to 100

Registry for shoulder replacement surgeries

Official title: Total Shoulder Arthroplasty Multi-Center Registry

Run by Arthrex, Inc. · NCT03511586 · Data updated 2026-11-12

This study is gathering information from people who are having shoulder replacement surgeries to see how well these procedures work and how they affect patients over time.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment2500 (estimated)
SponsorArthrex, Inc.
Industry-sponsored
Locations27 sites (Phoenix, Arizona and 26 other locations)
StatusRecruiting
StartedJuly 28, 2015
Main results expectedJuly 2035
Study endsNovember 2035
Registry record updatedAugust 20, 2026
Trial IDNCT03511586 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 100 who are planning to undergo primary or revision shoulder arthroplasty with an Arthrex prosthesis.

Probably not a fit

Patients with co-morbidities or obligations that would prevent them from participating in the study may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study is a multi-center prospective registry aimed at collecting clinical outcomes from patients undergoing anatomic and reverse total shoulder arthroplasty. Participants will be treated according to standard care at their respective centers and will be approached for enrollment after deciding to undergo shoulder arthroplasty. The study aims to enroll at least 500 patients for each type of shoulder arthroplasty, gathering data to evaluate the effectiveness and outcomes of these procedures. The registry will help in understanding the long-term results and patient experiences associated with shoulder replacements.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights that improve surgical outcomes and patient care for shoulder arthroplasty.

How similar studies have gone: Other similar registries have shown success in improving surgical practices and patient outcomes, indicating a positive precedent for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.
2. Patient is between the ages of 18 and 100 years.
3. The patient has a planned primary or revision implantation of an anatomic (hemi-arthroplasty or total arthroplasty) or a reverse shoulder prosthesis system manufactured by Arthrex.
4. Patient has a standard of care preoperative CT taken within 6 months that has been submitted for Arthrex VIP (Virtual Implant Positioning) planning (not required for acute humeral fractures).

Exclusion Criteria

1\. Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study.

Where it's running

  • University of Arizona/Banner Health
    Phoenix, Arizona, United States
    Recruiting
  • Banner Medical Group
    Phoenix, Arizona, United States
    Recruiting
  • Orthopedic Surgery (Mayo Scottsdale)
    Phoenix, Arizona, United States
    Recruiting
  • HCA Research Institute LLC.
    Denver, Colorado, United States
    Recruiting
  • University of Florida
    Gainesville, Florida, United States
    Recruiting
  • Andrews Research & Education Foundation
    Gulf Breeze, Florida, United States
    Recruiting
Show 21 more locations
  • Advent Health Orlando
    Orlando, Florida, United States
    Recruiting
  • The Trustees of Indiana University
    Indianapolis, Indiana, United States
    Recruiting
  • The University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • University of North Carolina
    Chapel Hill, North Carolina, United States
    Recruiting
  • Southern Oregon Orthopedics
    Medford, Oregon, United States
    Recruiting
  • The Hawkins Foundation
    Greenville, South Carolina, United States
    Recruiting
  • Campbell Foundation
    Germantown, Tennessee, United States
    Recruiting
  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting
  • Jordan Young Institute
    Virginia Beach, Virginia, United States
    Recruiting
  • Orthopädische Chirurgie München (OCM)
    München, Germany
    Recruiting
  • Schulthess Klinik
    Zurich, Switzerland
    Recruiting
  • Wrightington Hospital
    Wigan, United Kingdom
    Recruiting
  • University of Connecticut Health Center
    Farmington, Connecticut, United States
    Terminated
  • NorthShore University Health System
    Evanston, Illinois, United States
    Withdrawn
  • Grand Rapids, Michigan, United States Terminated
  • Columbia, Missouri, United States Terminated
  • The Rothman Institute
    New York, New York, United States
    Terminated
  • Wake Forest University Health Sciences
    Winston-Salem, North Carolina, United States
    Not yet recruiting
  • Cleveland Shoulder Institute
    Beachwood, Ohio, United States
    Active not recruiting
  • Rothman Orthopaedic Institute
    Philadelphia, Pennsylvania, United States
    Active not recruiting
  • Universitätsklinik Balgrist
    Zurich, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.